Literature DB >> 25856411

Lung Cancer Screening: Computed Tomography Radiation and Protocols.

Venkatesh A Murugan1, Mannudeep K Kalra, Madan Rehani, Subba R Digumarthy.   

Abstract

Recent studies have supported the use of low-dose computed tomography (LDCT) of the chest as a screening tool for lung cancer. Several professional organizations have now included LDCT screening in high-risk populations in their guidelines. The United States Preventive Services Task Force has added LDCT to its lung cancer-screening guidelines as of December 2013. Recently, the Centers for Medicare and Medicaid Services acknowledged that the evidence for LDCT lung cancer screening is adequate, provided that eligibility criteria are met. As widespread use of LDCT is anticipated, the radiation dose associated with LDCT needs to be optimized. The American College of Radiology-Society of Thoracic Radiology collaboration and the National Comprehensive Cancer Care Network recently provided some guidelines for LDCT utilization for lung cancer screening. There are several scanning and image reconstruction techniques that can be used for reducing radiation dose in LDCT lung cancer screening. This review article presents protocols and guidelines for use of LDCT in lung cancer screening and describes our early experience in implementing LDCT at our institution.

Entities:  

Mesh:

Year:  2015        PMID: 25856411     DOI: 10.1097/RTI.0000000000000150

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

1.  Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT: A phantom study.

Authors:  Kostas Perisinakis; Ioannis Seimenis; Antonis Tzedakis; Apostolos Karantanas; John Damilakis
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

2.  Assessment and Efficacy of Low-Dose CT Screening and Primary Care Providers Perspective on Lung Cancer Screening: An Institutional Review.

Authors:  Manan Shah; Phani K Surapaneni; Kirat Sandhu; Saba Shafi; Temidayo Abe; Sanjay Jain; Gabriela Oprea; Judith Volcy
Journal:  Cureus       Date:  2021-03-09

3.  Magnetic Resonance Spectroscopy-based Metabolomic Biomarkers for Typing, Staging, and Survival Estimation of Early-Stage Human Lung Cancer.

Authors:  Yannick Berker; Lindsey A Vandergrift; Isabel Wagner; Li Su; Johannes Kurth; Andreas Schuler; Sarah S Dinges; Piet Habbel; Johannes Nowak; Eugene Mark; Martin J Aryee; David C Christiani; Leo L Cheng
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.